Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-115

so, my view fwiw after holding since the IPO is that if you read the reports and take away as I did that this is the real deal, this is a fantastic opportunity. There is so much pressure on the down side that even a miracle won’t budge the price upwards atm. Yet at some point PAR, finances allowing, will start marketing and selling a product that has a massive market and works. The “vibe” is that future earnings count for nothing today. Yet if the reports are as they seem this is a no brainer. I understand why folks sold today and last time; am expecting more to bail
tomorrow: for them this is an opportunity to get out relatively unscathed. But for long term holders this is the result we were hoping for and an opportunity to top up that is unprecedented (if you read the reports and understand the science and trust management!).